Evaluation of Quality of Life and Utilities Following Surgical Treatment of Stage I-IV Rectal Cancer
GJ
Overseen byGeorge J Chang
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: M.D. Anderson Cancer Center
No Placebo Group
Trial Summary
What is the purpose of this trial?
This study evaluates quality of life and utilities following surgical treatment of stage I-IV rectal cancer. This study may help researches learn more about quality of life in patients who have or have had rectal cancer.
Research Team
GJ
George J Chang
Principal Investigator
M.D. Anderson Cancer Center
Eligibility Criteria
Inclusion Criteria
Patient has histologically proven adenocarcinoma of the rectum (stage I - IV) that is planned to be treated by surgical resection performed with curative intent, or who has already received surgical treatment
Patient must sign an approved informed consent document and have the literary and physical ability to complete the questionnaire in English
Treatment Details
Interventions
- Quality-of-Life Assessment (Behavioural Intervention)
- Questionnaire Administration (Behavioural Intervention)
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Observational (questionnaire)Experimental Treatment2 Interventions
Patients complete quality of life questionnaires over 20-30 minutes at baseline, 6 and 12 months after surgery, and 2, 3, 4, and 5 years after surgery.
Find a Clinic Near You
Who Is Running the Clinical Trial?
M.D. Anderson Cancer Center
Lead Sponsor
Trials
3,107
Recruited
1,813,000+
Dr. Peter WT Pisters
M.D. Anderson Cancer Center
Chief Executive Officer since 2017
MD from University of Western Ontario
Dr. Jeffrey E. Lee
M.D. Anderson Cancer Center
Chief Medical Officer
MD from Stanford University School of Medicine